Eradicating Barrett's Esophagus Using Radiofrequency Ablation or a Novel Hybrid Argon Plasma Coagulation Technique

NATerminatedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

July 24, 2019

Primary Completion Date

May 5, 2021

Study Completion Date

May 5, 2021

Conditions
Barrett's EsophagusHigh-grade Dysplasia in Barrett EsophagusLow Grade Dysplasia in Barrett Esophagus
Interventions
DEVICE

Hybrid argon plasma ablation (HAPC)

-The assigned HAPC ablation will be performed at 8 to 12 week intervals until eradication of BE has been achieved or a total of 4 treatments have been performed

DEVICE

Radiofrequency ablation (RFA)

-The assigned RFA procedure will be performed at 8 to 12 week intervals until eradication of BE has been achieved or a total of 4 treatments have been performed

Trial Locations (13)

10032

Columbia University Medical Center; Division of Digestive and Liver Diseases, New York

11030

Long Island Jewish Medical Center, New Hyde Park

17033

Penn State Hershey Medical Center, Hershey

32224

Mayo Clinic Florida, Jacksonville

55905

Mayo Clinic, Rochester

60687

University of Chicago, Chicago

63110

Washington University, School of Medicine; Department of Internal Medicine; Division of Gastroenterology, St Louis

64128

Kansas City Veterans Affairs Hospital, Kansas City

80045

University of Colorado, Aurora

84132

University of Utah School of Medicine, Salt Lake City

85259

Mayo Clinic Arizona, Scottsdale

92868

University of California, Irvine

03766

Dartmouth-Hitchcock Medical Center, Lebanon

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Erbe USA Incorporated

OTHER

collaborator

Kansas City Veteran Affairs Medical Center

FED

collaborator

NAMSA

OTHER

lead

Erbe Elektromedizin GmbH

INDUSTRY

NCT03621319 - Eradicating Barrett's Esophagus Using Radiofrequency Ablation or a Novel Hybrid Argon Plasma Coagulation Technique | Biotech Hunter | Biotech Hunter